Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31…
As filed · Jeena Sikho Lifecare Limited has submitted to the Exchange, Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
What happened
FactJeena Sikho Lifecare Limited's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026, which received an unmodified opinion from the statutory auditors. Additionally, the board recommended a final dividend of Rs. 4.50 per equity share for the financial year 2025-26, pending shareholder approval at the upcoming Annual General Meeting.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
RevisedBoth the IPD and OPD segments registered robust increases of 57% YoY and 67% YoY, respectively.
Revenue from Operations grew by an impressive 92% YOY in Q3 and 78% YOY for 9MFY26.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We have an additional six product launches planned for the remainder of the year, underscoring our continued c (management committed by FY26)
Evidence
- Jeena Sikho Lifecare Limited has informed the Exchange regarding Change in Auditors of the company.(opens the original filing in a new tab)
- Earlier statement · Q2 FY25
- Latest statement · Q3 FY25
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +6 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%